Angioedema following initiation of glecaprevir/pibrentasvir while on sitagliptin.

Schneider, Amanda; Ramesh, Manish

Schneider, Amanda; Ramesh, Manish.

Affiliation

Schneider A; Division of Allergy and Immunology, Montefiore Medical Center, Bronx, NY.
Ramesh M; Division of Allergy and Immunology, Montefiore Medical Center, Bronx, NY. Electronic address: mramesh@montefiore.org.

J Allergy Clin Immunol Pract ; 7(6): 2068-2069, 2019.

Article in En | MEDLINE | ID: mdl-30779957

Subject(s)

Angioedema/chemically induced; Antiviral Agents/adverse effects; Benzimidazoles/adverse effects; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Quinoxalines/adverse effects; Sitagliptin Phosphate/adverse effects; Sulfonamides/adverse effects; Aged; Aminoisobutyric Acids; Cyclopropanes; Diabetes Mellitus, Type 2/drug therapy; Drug Interactions; Drug Therapy, Combination; Female; Hepatitis C/drug therapy; Humans; Hypoglycemia/chemically induced; Lactams, Macrocyclic; Leucine/analogs & derivatives; Proline/analogs & derivatives; Pyrrolidines

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antiviral Agents / Quinoxalines / Sulfonamides / Benzimidazoles / Dipeptidyl-Peptidase IV Inhibitors / Sitagliptin Phosphate / Angioedema Limits: Aged / Female / Humans Language: En Journal: J Allergy Clin Immunol Pract Year: 2019 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google